Syra Health Corp.
SYRA
$0.097
-$0.001-1.02%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.76% | -7.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.76% | -7.42% | |||
| Cost of Revenue | -5.94% | -18.23% | |||
| Gross Profit | 27.78% | 29.38% | |||
| SG&A Expenses | -23.38% | 6.66% | |||
| Depreciation & Amortization | -11.76% | -6.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.80% | -7.07% | |||
| Operating Income | 86.65% | 5.66% | |||
| Income Before Tax | 86.53% | 6.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 86.53% | 6.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 86.53% | 6.36% | |||
| EBIT | 86.65% | 5.66% | |||
| EBITDA | 87.74% | 5.64% | |||
| EPS Basic | 87.01% | 20.47% | |||
| Normalized Basic EPS | 87.06% | 20.31% | |||
| EPS Diluted | 87.01% | 20.47% | |||
| Normalized Diluted EPS | 87.06% | 20.31% | |||
| Average Basic Shares Outstanding | 3.04% | 17.77% | |||
| Average Diluted Shares Outstanding | 3.04% | 17.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||